Inhibition of LDHA can sensitize CRC cells to rapamycin, and the combined use of rapamycin with the glycolysis inhibitor oxamate exhibits a potent inhibitory effect on CRC [141]. This evidence concerns the gene LDHA and colorectal carcinoma.